Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
203 studies found for:    "Osteoporosis, Postmenopausal"
Show Display Options
Download search resultsDownload the search results for:
"Osteoporosis, Postmenopausal" (203 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: E2 transdermal (Julina, BAY86-5435)
2 Completed Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment
Condition: Osteoporosis, Postmenopausal
Intervention: Other: OPSAT-Q
3 Completed 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Teriparatide;   Drug: Raloxifene
4 Completed Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: ibandronate, calcium and vitamin D;   Drug: placebo,calcium and vitamin D
5 Completed Julina Post-marketing Surveillance for Climacteric Symptoms in Japan
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: E2 transdermal (Julina, BAY86-5435)
6 Completed Study With AMG 785 to Treat Japanese Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis (PMO)
Interventions: Drug: AMG 785;   Drug: Placebo
7 Completed Risedronate Sodium in Post Menopausal Osteoporosis
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: risedronate sodium
8 Completed Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Intervention: Drug: Teriparatide
9 Completed
Has Results
Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical Practice
Condition: Osteoporosis, Postmenopausal
Intervention: Biological: Denosumab
10 Completed Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan
Condition: Postmenopausal Osteoporosis
Intervention:
11 Not yet recruiting The Deferasirox-calcium-vitamin D3 Therapy for Postmenopausal Osteoporosis (PMOP)
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Deferasirox and calcium-vitamin D3;   Drug: Calcium-vitamin D3
12 Completed
Has Results
Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: AMG 162;   Drug: Placebo
13 Completed
Has Results
Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women
Condition: Postmenopausal Osteoporosis
Interventions: Drug: menatetranone;   Drug: alfacalcidol
14 Unknown  Study on the microRNA Expression Level in Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Other: osteoporosis
15 Enrolling by invitation Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Other: Observation
16 No longer available A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
Condition: Postmenopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
17 Completed BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
18 Completed
Has Results
A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Ibandronate
19 Completed A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Alendronate;   Drug: Ibandronate
20 Completed Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Ibandronate (SB743830HD)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.